Medpage Today on MSN13h
Pulled Myeloma Drug Improves Survival in TrialA significant overall survival (OS) benefit with belantamab mafodotin (belantamab; Blenrep) in a phase III trial of relapsed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback